Table 7.
Clinical context |
Sarcoma | Keratin expression* |
IHC markers | References |
---|---|---|---|---|
Primary | Malignant solitary fibrous tumor |
+/− | STAT6, CD34, BCL6 | 199–203 |
Inflammatory Myofibroblastic tumor |
+/− | ALK, SMA, FISH for ALK, ROS1, RET, NTRK3 fusions |
204–206 | |
Primary pleural synovial sarcoma |
+/− | TLE1, focal keratins, FISH for SSI8 fusions | 207 | |
Metastatic | Uterine leiomyosarcoma | +/− | SMA, ER, desmin | |
De-differentiated liposarcoma |
− | CDK4, MDM2 | ||
Malignant peripheral nerve sheath tumor |
− | SOX 10, S100, H3K27me3 loss | ||
Malignant melanoma | − | SOX 10, Melan A, HMB45, SI00 |
usually focal and weak, but diffuse positive reactions can occur